Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments;Épithélium conjonctival et glaucome: Analyse par cytofluorimétrie en flux de l'expression des marqueurs inflammatoires HLA-DR, IL-6 et IL-8 chez les patients traités

Journal Francais d'Ophtalmologie

Volumn 26, Issue 8, 2003, Pages 782-789

  Bensoussan, L ^c   Blondin, C ^c   Baudouin, C ^a,b   Hamard, P ^c   Sabeh Afaki, G ^c   Creuzot Garcher, C ^c   Warnet, J M ^c   Brignole Baudouin, F ^c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^c NONE

Author keywords

Antiglaucoma drugs; Conjunctiva; Cytokines; Flow cytometry; Inflammation

Indexed keywords

ANTIGLAUCOMA AGENT; BENZALKONIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; DRUG PRESERVATIVE; EYE DROPS; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN DERIVATIVE; CARBONATE DEHYDRATASE INHIBITOR; PRESERVATIVE; PROSTAGLANDIN;

ALLERGY; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMPRESSION CYTOLOGY; INFLAMMATION; OPEN ANGLE GLAUCOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RELIABILITY; STANDARD; COMPARATIVE STUDY; CONJUNCTIVA; CYTOLOGY; CYTOPLASM; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLAUCOMA; IMMUNOLOGY; MALE; STATISTICAL ANALYSIS; TIME;

ADRENERGIC BETA-ANTAGONISTS; BENZALKONIUM COMPOUNDS; CARBONIC ANHYDRASE INHIBITORS; CONJUNCTIVA; CYTOLOGICAL TECHNIQUES; CYTOPLASM; DATA INTERPRETATION, STATISTICAL; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; PROSTAGLANDINS; TIME FACTORS;

EID: 0242299779     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556-63.
2. Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol 1993;77:590-6.
3. Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998; 17:419-25.
4. Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1994;232:561-5.
5. Thorpe R, Wadhwa M, Bird CR, Mire-Sluis AR. Detection and measurement of cytokines. Blood Rev 1992;6:133-48.
6. Liles WC, Van Voorhis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995;172:1573-80.
7. Murray PI, Hoekzema R, van Haren MA, de Hon FD, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 1990;31:917-20.
8. Hoekzema R, Murray Pi, Kijlstra A. Cytokines and intraocular inflammation. Curr Eye Res 1990;9 Suppl:207-11.
9. Hoekzema R, Murray PI, van Haren MA, Helle M, Kijlstra A. Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1991;32:88-95.
10. Hoekzema R, Verhagen C, van Haren M, Kijlstra A. Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6. Invest Ophthalmol Vis Sci 1992;33:532-9.
11. Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K, et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 1999;40:28-34.
12. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci 1994;35:924-30.
13. Franks WA, Limb GA, Stanford MR, Ogilvie J, Wolstencroft RA, Chignell AH, et al. Cytokines in human intraocular inflammation. Curr Eye Res 1992;11 Suppl:187-91.
14. Gonzalez P, Epstein DL, Borras T. Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000;41:352-61.
15. Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M, Reis BL. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 2000;19:492-6.
16. Gamache DA, Dimitrijevich SD, Weimer LK, Lang LS, Spellman JM, Graff G, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm 1997;5:117-28.
17. Ferrick MR, Thurau SR, Oppenheim MH, Herbort CP, Ni M, Zachariae CO, et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 1991;32:1534-39.
18. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-49.
19. Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 1994;101:454-60.
20. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 2000;20:85-94.
21. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 1989;96:327-35.
22. Nuzzi R, Vercelli A, Finazzo C, Cracco C. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 1995;233:154-62.
23. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci 1997;38:1458-64.
24. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41:1356-63.
25. Pisella PJ, Brignole F, Debbasch C, Lozato PA, Creuzot-Garcher C, Bara J, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology 2000;107:1841-49.
26. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 1992;76:545-9.
27. Baudouin C, Fredj-Reygrobellet D, Gastaud P, Lapalus P. HLA DR and DQ distribution in normal human ocular structures. Curr Eye Res 1988;7:903-11.
28. Foulis AK, Farquharson MA. Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus. Diabetes 1986;35:1215-24.
29. Hoh H. [Preservative-free timolol eye drops-surface-anesthetic effect and local compatibility]. Ophtalmologica 1990;200:89-97.
30. Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002;86:418-23.
31. Pisella P, Parier. V, Megherbi C, Brignole F, C. Baudouin. Toxicité des conservateurs sur les cellules épithéliales de la conjonctive: comparaison de l'effet du timolol avec conservateur et sans conservateur dans le glaucome chronique à angle ouvert. J Fr Ophtalmol; 2003;26:675-9.
32. Mietz H, Schlotzer-Schrehardt U, Strassfeld C, Krieglstein GK. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 2001;42:679-87.